| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J53-008 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J53-00 |
| filingDate |
1981-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_863caa212961457b629b1f48ac1ddff1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3da95067f90e6a52dd209b488e8223a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b689ed9744078cc777a98a3df1607b8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43f2cd06124280737d8a8949d07026f7 |
| publicationDate |
1982-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-3111950-A1 |
| titleOfInvention |
7 (ALPHA) -ALKOXYCARBONYL-15 (BETA) .16 (BETA) -METHYLENE-4-ANDROSTEN-3-ONE, METHOD FOR THE PRODUCTION AND USE THEREOF AS A MEDICINAL PRODUCT |
| abstract |
The invention relates to 7 alpha -alkoxycarbonyl-15 beta ,16 beta -methylene-4-androsten-3-ones of the general formula I <IMAGE> in which R<1> is a hydrogen atom or a methyl group, R<2> is an alkyl group with 1 to 4 carbon atoms, X is the group <IMAGE> and the bond between carbon atoms 1 and 2 is saturated or represents a double bond. The compounds according to the invention have valuable pharmacological properties as aldosterone antagonists, i.e. they reverse the effect of deoxycorticosterone on the excretion of sodium and potassium. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101511857-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I413645-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2433951-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008000521-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7846917-B2 |
| priorityDate |
1981-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |